Cerebral Metastases: Translational Advances, Evaluation and Management

Erscheinungsjahr 2025
ISBN: 978-0-443-34591-3
Verlag: Elsevier Science & Technology

Buch, Englisch, Format (B × H): 152 mm x 229 mm, Gewicht: 450 g

Cerebral Metastases: Translational Advances, Evaluation and Management, Volume 165 in this ongoing series, highlights new advances in the field, with this new volume covering many interesting topics, including Molecular Drivers in CNS metastasis, Role of the tumor microenvironment in CNS metastatic disease, Advanced Imaging to improve early diagnosis and evaluate treatment response, Liquid biopsy in early detection of CNS metastasis, Precision medicine approaches to CNS metastatic disease, IMRT/conventional RT, Single and hypofractionated SRS, Brachytherapy for recurrent metastases, LITT for treatment of active brain metastasis and radiation necrosis, and much more.

Other topics covered include Minimally-invasive surgical approaches in the management of brain metastases.

Autoren/Hrsg.

Weitere Mitwirkende

Daras, Mariza

Limbrick, David

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie
• Naturwissenschaften Biowissenschaften Mikrobiologie
• Naturwissenschaften Biowissenschaften Zellbiologie
• Naturwissenschaften Biowissenschaften Biowissenschaften Genetik und Genomik (nichtmedizinisch)

Inhaltsverzeichnis

1. Molecular Drivers in CNS metastasis
Akanksha Sharma
2. Role of the tumor microenvironment in CNS metastatic disease
Adrienne Boire
3. Advanced Imaging to improve early diagnosis and evaluate treatment response
Javier E. Villanueva-Meyer
4. Liquid biopsy in early detection of CNS metastasis
Rachna Malani
5. Precision medicine approaches to CNS metastatic disease
Seema Nagpal
6. IMRT/conventional RT
Timothy Harris
7. Single and hypofractionated SRS
Jason P. Sheehan, Stylianos Pikis and Georgios Mantziaris
8. Brachytherapy for recurrent metastases
Steve Braunstein
9. LITT for treatment of active brain metastasis and radiation necrosis
Bill Broaddus, Theresa Gammel and Shawn D'Souza
10. Minimally-invasive surgical approaches in the management of brain metastases
Brian Nahed, Nicole Perez and Bryan Choi

Über Autor(innen)

Daras, Mariza
Dr. Mariza Daras is an Associate professor in the Department of Neurosurgery and the Chief of Neuro-oncology at Virginia Commonwealth University's Massey Comprehensive Cancer Center in Richmond, Virginia. She began her academic medical career at Columbia College of Physicians and Surgeons, where she received her medical degree. After completing her Neurology residency at Duke University Medical Center and a Neuro-oncology fellowship at Memorial Sloan Kettering, she served as faculty in the Department of Neurology at Memorial Sloan Kettering. She subsequently took on a faculty position in the Division of Neuro-oncology at the University of California San Francisco where she spearheaded a CNS metastasis multidisciplinary program. In 2019, she joined VCU to lead the Division of Neuro-oncology. Dr. Daras has focused her research efforts on clinical trials for patients with primary and metastatic brain tumors, and specifically in the development of novel immunotherapeutic and combinatorial strategies. She has also dedicated her time to teaching and mentoring medical school students, residents, fellows, and advanced practice providers and is the Program Director of the VCU neuro-oncology fellowship. She is board-certified by the American Board of Psychiatry and Neurology and the United Council of Neurologic Subspecialties for neuro-oncology. Dr. Daras is a member of the American Academy of Neurology (AAN), Society for Neuro-Oncology (SNO), and American Society of Clinical Oncology (ASCO). She is an appointed member of AAN's Committee on Public Engagement, as well as the AAN, Committee on Brain Health. She also serves as appointed member of the SNO Diversity and Women Committee, as well as the SNO/ASCO CNS Metastases Annual Conference.